Draghia-Akli Ruxandra
Health Directorate, Directorate-General for Research & Innovation, European Commission, Brussels, Belgium.
Per Med. 2012 Mar;9(2):151-155. doi: 10.2217/pme.11.91.
The potential benefits that personalized medicine approaches can bring to healthcare are discussed with much interest throughout the EU. This novel approach is based on a better understanding of the molecular mechanisms of health and disease and it has now begun to show results. There is, however, a long way to go before the area is fully exploited. This special report reviews the European Commission's funding activities related to personalized medicine research. Although the specific focus on personalized medicine is relatively new, the European Commission has already committed significant funding to research in enabling technologies relevant to the field, as well as to specific disease areas for their application. A stocktaking exercise which started in 2010 has helped identify immediate and future challenges in personalized medicine research. The outcome of this exercise, summarized below, will contribute to developing a vision for future research funding at the EU level.
在整个欧盟,人们饶有兴趣地讨论了个性化医疗方法可能给医疗保健带来的潜在益处。这种新颖的方法基于对健康和疾病分子机制的更深入理解,并且现已开始显现出成果。然而,在该领域得到充分利用之前,仍有很长的路要走。这份特别报告回顾了欧盟委员会与个性化医疗研究相关的资助活动。尽管对个性化医疗的具体关注相对较新,但欧盟委员会已经为该领域相关的使能技术研究以及特定疾病领域的应用投入了大量资金。始于2010年的一次清查活动有助于确定个性化医疗研究当前和未来面临的挑战。以下总结的这次清查活动的结果,将有助于制定欧盟层面未来研究资助的愿景。